Published in Vaccine Weekly, August 30th, 2000
"Photoimmunotherapy (using a MAb-targeted photosensitizer and red light) may be a strategy to overcome the limitations inherent in photodynamic therapy of liver tumors," reported M.R. Hamblin and colleagues from several institutions in the United States and Italy. "The aims were 1) to test the efficacy of selective treatment of hepatic metastases of colorectal cancer in an orthotopic murine xenograft using the murine MAb 17.1A conjugated to the photosensitizer chlorin e6, and 2) to compare the tumor response after...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.